Ownership history in UBS Group AG · 13 quarters on record
This page tracks every 13F SEC filing in which UBS Group AG reported a position in INDAPTUS THERAPEUTICS INC (INDP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 29,002 | +28,500 | +5677.3% | 0.00% | $84K | $2.91 |
| 2025 Q3 | ADDED | 502 | +415 | +477.0% | 0.00% | $1K | $2.87 |
| 2025 Q1 | REDUCED | 87 | -2,436 | -96.6% | 0.00% | $49 | $15.40 |
| 2024 Q4 | ADDED | 2,523 | +2,001 | +383.3% | 0.00% | $2K | $23.58 |
| 2024 Q3 | REDUCED | 522 | -170 | -24.6% | 0.00% | $647 | $34.72 |
| 2024 Q2 | REDUCED | 692 | -1,244 | -64.3% | 0.00% | $1K | $59.36 |
| 2024 Q1 | REDUCED | 1,936 | -1,763 | -47.7% | 0.00% | $4K | $62.72 |
| 2023 Q4 | ADDED | 3,699 | +3,562 | +2600.0% | 0.00% | $7K | $49.28 |
| 2023 Q3 | REDUCED | 137 | -503 | -78.6% | 0.00% | $377 | $77.14 |
| 2023 Q2 | REDUCED | 640 | -2,654 | -80.6% | 0.00% | $1K | $53.48 |